fda to stop compounded semaglutide & Tirzepatide 2025: Safe Use Guide FDA says 'no clinical need'

There is no government-ID upload, no phone-number OTP verification, no labs upload, and no weight documentation

It promotes weight loss by sending signals to the appetite center in your brain to reduce hunger and increase fullness, making it easier to manage hunger cues, stick to smaller and fewer meals and overcome emotional or boredom eating

Mindful Eating: Pay attention to hunger and fullness cues

Semaglutide aids weight loss by slowing stomach emptying and sending signals to your brain that you are full, helping you naturally reduce food intake

At the time of the study in early 2024, about 0.5% of the adult population in the US was using GLP - 1 therapies